CONTRIBUTIONS OF CONSERVED SERINE RESIDUES TO THE INTERACTIONS OF LIGANDS WITH DOPAMINE-D2 RECEPTORS

被引:134
作者
COX, BA
HENNINGSEN, RA
SPANOYANNIS, A
NEVE, RL
NEVE, KA
机构
[1] VET AFFAIRS MED CTR,MED RES SERV 151LL,3710 SW US VET HOSP RD,PORTLAND,OR 97207
[2] UNIV CALIF IRVINE,DEPT PSYCHOBIOL,IRVINE,CA 92717
[3] OREGON HLTH SCI UNIV,DEPT PHARMACOL,PORTLAND,OR 97201
[4] OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201
关键词
DOPAMINE; DOPAMINE-D2; RECEPTORS; CDNA; AGONIST;
D O I
10.1111/j.1471-4159.1992.tb09416.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four dopamine D2 receptor mutants were constructed, in each of which an alanine residue was substituted for one of four conserved serine residues, i.e., Ser-193, Ser-194, Ser-197, and Ser-391. Wild-type and mutant receptors were expressed transiently in COS-7 cells and stably in C6 glioma cells for analysis of ligand-receptor interactions. In radioligand binding assays, the affinity of D2 receptors for dopamine was decreased 50-fold by substitution of alanine for Ser-193, implicating this residue in the binding of dopamine. Each mutant had smaller decreases in affinity for one or more of the ligands tested, with no apparent relationship between the class of ligand and the pattern of mutation-induced changes in affinity, except that the potency of agonists was decreased by substitution for Ser-193. The potency of dopamine for inhibition of adenylyl cyclase was reduced substantially by substitution of alanine for Ser-193 or Ser-197. Mutation of Ser-194 led to a complete loss of efficacy for dopamine and p-tyramine, which would be consistent with an interaction between Ser-194 and the p-hydroxyl substituent of dopamine that is necessary for activation of the receptors to occur. Because mutation of the corresponding residues Of beta-2-adrenergic receptors has very different consequences, we conclude that although the position of these serine residues is highly conserved among catecholamine receptors, and the residues as a group are important in ligand binding and activation of receptors by agonists, the function of each of the residues considered separately varies among catecholamine receptors.
引用
收藏
页码:627 / 635
页数:9
相关论文
共 30 条
[1]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[2]  
CHEN CA, 1988, BIOTECHNIQUES, V6, P632
[3]  
CHUNG FZ, 1988, J BIOL CHEM, V263, P4052
[4]   PREPARATION OF [I-123] EPIDEPRIDE AND [I-125] EPIDEPRIDE - A DOPAMINE D-2 RECEPTOR ANTAGONIST RADIOLIGAND [J].
CLANTON, JA ;
DEPAULIS, T ;
SCHMIDT, DE ;
ANSARI, MS ;
MANNING, RG ;
BALDWIN, RM ;
KESSLER, RM .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1991, 29 (07) :745-751
[5]   STEREOELECTRONIC STUDY OF ZETIDOLINE, A DOPAMINE-D2 RECEPTOR ANTAGONIST [J].
COLLIN, S ;
EVRARD, G ;
VERCAUTEREN, DP ;
DURANT, F ;
CARRUPT, PA ;
VANDEWATERBEEMD, H ;
TESTA, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) :38-42
[6]   MOLECULAR-CLONING AND EXPRESSION OF THE GENE FOR A HUMAN D1 DOPAMINE RECEPTOR [J].
DEARRY, A ;
GINGRICH, JA ;
FALARDEAU, P ;
FREMEAU, RT ;
BATES, MD ;
CARON, MG .
NATURE, 1990, 347 (6288) :72-76
[7]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121
[8]  
FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339
[9]  
FRASER CM, 1989, MOL PHARMACOL, V36, P840
[10]   HIGH-EFFICIENCY DNA-MEDIATED TRANSFORMATION OF PRIMATE CELLS [J].
GORMAN, C ;
PADMANABHAN, R ;
HOWARD, BH .
SCIENCE, 1983, 221 (4610) :551-553